These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37668799)

  • 41. Construction of a New Immune-Related Competing Endogenous RNA Network with Prognostic Value in Lung Adenocarcinoma.
    Liu L; Li J; Fan C; Wen M; Li C; Sun W; Wang W
    Mol Biotechnol; 2024 Feb; 66(2):300-310. PubMed ID: 37118319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Comprehensive Prognostic Model for Colon Adenocarcinoma Depending on Nuclear-Mitochondrial-Related Genes.
    Lv L; Huang Y; Li Q; Wu Y; Zheng L
    Technol Cancer Res Treat; 2024; 23():15330338241258570. PubMed ID: 38832431
    [No Abstract]   [Full Text] [Related]  

  • 43. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
    Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
    Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Revealing potential immunotherapy targets through analysis of a ceRNA network in human colon adenocarcinoma.
    Li C; Zhu Z; Hou Q; Wang B; Zou L; Liu L; Gong W; Guo H
    Transl Cancer Res; 2021 Dec; 10(12):5319-5336. PubMed ID: 35116380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of immunity-related lncRNAs and construction of a ceRNA network of potential prognostic biomarkers in acute myeloid leukemia.
    Xue J; Chen H; Lu J; Zhang H; Geng J; He P; Lu X
    Front Genet; 2023; 14():1203345. PubMed ID: 37388937
    [No Abstract]   [Full Text] [Related]  

  • 46. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis.
    Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N
    Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

  • 48. Construction and Validation of Pyroptosis-Related lncRNA Prediction Model for Colon Adenocarcinoma and Immune Infiltration Analysis.
    Liu Q; Chen N; Liu L; Zheng Q; Liao W; Zhao M; Zeng J; Tang J
    Dis Markers; 2022; 2022():4492608. PubMed ID: 36168326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of Immune-Related Gene Signature and Prediction of CeRNA Network in Active Ulcerative Colitis.
    Xu M; Kong Y; Chen N; Peng W; Zi R; Jiang M; Zhu J; Wang Y; Yue J; Lv J; Zeng Y; Chin YE
    Front Immunol; 2022; 13():855645. PubMed ID: 35392084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma.
    Ren Z; Wang Z; Gu D; Ma H; Zhu Y; Cai M; Zhang J
    Front Cell Dev Biol; 2021; 9():740455. PubMed ID: 34746134
    [No Abstract]   [Full Text] [Related]  

  • 51. ceRNA network-regulated COL1A2 high expression correlates with poor prognosis and immune infiltration in colon adenocarcinoma.
    Yuan X; He Y; Wang W
    Sci Rep; 2023 Oct; 13(1):16932. PubMed ID: 37805556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.
    Jin LP; Liu T; Meng FQ; Tai JD
    BMC Cancer; 2020 Oct; 20(1):968. PubMed ID: 33028275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
    Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
    Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of competitive endogenous RNAs network in breast cancer.
    Wang X; Wan J; Xu Z; Jiang S; Ji L; Liu Y; Zhai S; Cui R
    Cancer Med; 2019 May; 8(5):2392-2403. PubMed ID: 30932362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of a novel seven-gene expression signature with the disease prognosis in colon cancer patients.
    Yang H; Liu H; Lin HC; Gan D; Jin W; Cui C; Yan Y; Qian Y; Han C; Wang Z
    Aging (Albany NY); 2019 Oct; 11(19):8710-8727. PubMed ID: 31612869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
    Chen X; Cao W; Zhuang Y; Chen S; Li X
    Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets.
    Zhao P; Zhen H; Zhao H; Huang Y; Cao B
    J Transl Med; 2023 Mar; 21(1):176. PubMed ID: 36879254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma.
    Cheng X; Wei Y; Fu Y; Li J; Han L
    Front Immunol; 2022; 13():1052182. PubMed ID: 36532007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.
    Zeng Y; He T; Liu J; Li Z; Xie F; Chen C; Xing Y
    Medicine (Baltimore); 2020 Nov; 99(47):e23314. PubMed ID: 33217867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD.
    Wang S; Xu L; Zhu K; Zhu H; Zhang D; Wang C; Wang Q
    BMC Med Genomics; 2022 Dec; 15(1):260. PubMed ID: 36522691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.